Last update 21 Nov 2024
MY-008211A
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CFB inhibitors(Complement factor B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
21
Clinical Trials associated with MY-008211AA Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)
A Multi-center, Randomized, Parallel, Open-label Clinical Phase II Study, to Evaluate the Efficacy and Safety of MY008211A in Adult Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients With Signs of Active Hemolysis
A Single-center, Randomized, Double-blind, Single Oral Dose, Placebo-controlled Study to Evaluate the Effect of MY008211A Tablets on QTc Interval in Healthy Chinese Adult Subjects
100 Clinical Results associated with MY-008211A
Login to view more data
100 Translational Medicine associated with MY-008211A
Login to view more data
100 Patents (Medical) associated with MY-008211A
Login to view more data
1
Literatures (Medical) associated with MY-008211A20 Aug 2021Nucleic Acids ResearchQ2 · BIOLOGY
Targeting a noncanonical, hairpin-containing G-quadruplex structure from the MYCN gene
Q2 · BIOLOGY
ArticleOA
Author: Liu, Zhihui ; Xu, Man ; Bume, Desta D ; Schneekloth, John S ; Parmar, Shaifaly ; Yang, Mo ; Liang, Xiao ; Yazdani, Kamyar ; Calabrese, David R ; Thiele, Carol J ; Carter, Sakereh
100 Deals associated with MY-008211A
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hemoglobinuria, Paroxysmal | Phase 3 | CN | 07 Aug 2024 | |
| Glomerulonephritis, IGA | Phase 2 | - | - | |
| C3 glomerulopathy | IND Approval | CN | 18 Dec 2023 | |
| Diabetic Nephropathies | IND Approval | CN | 18 Dec 2023 | |
| Idiopathic Membranous Glomerulonephritis | IND Approval | CN | 18 Dec 2023 | |
| Lupus Nephritis | IND Approval | CN | 18 Dec 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | - | auzjfchrng(dxlcfemgfp) = n=15 of 34 patients avpuyvwagr (vuqeeovqlz ) View more | - | 08 Dec 2024 | |||
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free